Frontlight ResearchEarly access
Trial site
London
- 6running trials
- 1closed trial
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- High blood pressure2 trials
- Acute myeloid leukaemia1 trial
- Amyloidosis1 trial
- Childhood cancers1 trial
- Lichen planus1 trial
- Metastatic breast cancer1 trial
- Myasthenia gravis1 trial
- Phase
- Phase 34 trials
- Phase 21 trial
- Phase 2/31 trial
- Status
- Recruiting5 trials
- Active, not recruiting1 trial
- Completed1 trial
- Lead sponsor
- Alnylam Pharmaceuticals3 trials
- Alexion Pharmaceuticals, Inc.1 trial
- Olema Pharmaceuticals, Inc.1 trial
- Priovant Therapeutics, Inc.1 trial
- Syndax Pharmaceuticals1 trial
Running trials
Recruiting
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
Recruiting
Recruiting
Recruiting
Active, not recruiting
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Amyloidosis1 recruiting
- Childhood cancers1 recruiting
- High blood pressure1 recruiting
- Lichen planus1 recruiting
- Myasthenia gravis1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026